1Division of Nephrology and
3The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts;
Departments of 2Clinical Pharmacy and Pharmacology and
6Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;
4Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts;
5Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
7Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah;
8Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio;
9Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany;
10Division of Nephrology, RWTH Aachen University, Aachen, Germany;
11Division of Nephrology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong;
12George Institute for Global Health, University of New South Wales, Sydney, Australia; and
13Department of Preventive Medicine, Division of Biostatistics, Northwestern University, Chicago, Illinois
Correspondence: Dr. Lesley A. Inker, Division of Nephrology, Tufts Medical Center, 800 Washington Street, Box #391, Boston, MA 02111. Email: [email protected]
